Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hypersensitivity Reaction

Free Subscription Articles published in J Dermatol Retrieve available abstracts of 139 articles: HTML format

Single Articles

April 2024
1. SUGIURA R, Hashimoto T, Okuno S, Satoh T, et al
   Expression of phosphorylated-Janus kinase 1 and IL-4Ralpha by dermal basophils and epidermal keratinocytes in atopic dermatitis-associated prurigo nodules: A case report.
   J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17229.
   PubMed    
   
   
   
2. HANAMI Y, Yamamoto T
   Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis.
   J Dermatol. 2024 Apr 8. doi: 10.1111/1346-8138.17199.
   PubMed    
   
   
   
3. PAN X, Dong Z
   Yellow urticaria following plasma transfusion.
   J Dermatol. 2024;51:e108-e109.
   PubMed    
   
   
   
4. CHATPROEDPRAI S, Tiasiri N, Chantawarangkul K, Wananukul S, et al
   Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
   J Dermatol. 2024;51:509-517.
   PubMed     Abstract available
   
   
   March 2024
5. UCHIYAMA A, Kosaka K, Ishikawa M, Inoue Y, et al
   Real-world effectiveness and safety of abrocitinib in 12 Japanese patients with atopic dermatitis and transcriptome analysis with peripheral blood.
   J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17173.
   PubMed     Abstract available
   
   
   February 2024
6. KOJIMA R, Miyake K, Shinohara R, Kushima M, et al
   Association between filaggrin gene mutations and the clinical features of molluscum contagiosum: The Yamanashi Adjunct Study of the Japan Environment and Children's Study.
   J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17157.
   PubMed     Abstract available
   
   
   
7. YAZDANPARAST T, Nassiri Kashani M, Shamsipour M, Izadi Heidari F, et al
   Contact allergens responsible for eyelid dermatitis in adults.
   J Dermatol. 2024 Feb 13. doi: 10.1111/1346-8138.17140.
   PubMed     Abstract available
   
   
   
8. TAKAMATSU N, Nakamura K, Suzuki M, Ito A, et al
   Food-dependent exercise-induced anaphylaxis caused by leek and several allergens of the allium family.
   J Dermatol. 2024 Feb 12. doi: 10.1111/1346-8138.17141.
   PubMed     Abstract available
   
   
   
9. MUROTA H, Arima K, Yoshida T, Fujita H, et al
   Disease burden and treatment satisfaction in patients with prurigo nodularis in Japan.
   J Dermatol. 2024;51:223-233.
   PubMed     Abstract available
   
   
   
10. ARAI Y, Okamura K, Saito T, Ito Y, et al
    A case of acute localized exanthematous pustulosis following COVID-19 infection.
    J Dermatol. 2024;51:e37-e38.
    PubMed    
    
    
    
11. YAMASHITA A, Fukui T, Akasaka E, Nakajima K, et al
    Acquired cutis laxa secondary to acute generalized exanthematous pustulosis: A case report and mini-review of literature.
    J Dermatol. 2024;51:287-293.
    PubMed     Abstract available
    
    
    January 2024
12. SATOH TK, Neulinger MM, Stadler PC, Aoki R, et al
    Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications.
    J Dermatol. 2024;51:3-11.
    PubMed     Abstract available
    
    
    
13. CHEN L, Xu Q, Liu J, Li Z, et al
    Severe acute urticaria is associated with elevated plasma levels of D-dimer.
    J Dermatol. 2024;51:81-87.
    PubMed     Abstract available
    
    
    December 2023
14. MASUDA T, Yonekura S, Kataoka K, Mizoguchi K, et al
    Psoriasis-like lesions in an atopic dermatitis patient possibly associated with nemolizumab treatment.
    J Dermatol. 2023 Dec 27. doi: 10.1111/1346-8138.17085.
    PubMed    
    
    
    
15. NAKAIZUMI H, Kambe N, Irie H, Kaku Y, et al
    Neutrophilic epitheliotropism, proposed as an auto-inflammatory condition of neutrophilic urticarial dermatosis including Schnitzler syndrome, is also observed in Japanese cases.
    J Dermatol. 2023 Dec 6. doi: 10.1111/1346-8138.17067.
    PubMed     Abstract available
    
    
    November 2023
16. BOCHI-KURIMOTO M, Sakai T, Goto H, Miyazaki S, et al
    Management of severe allergy, reacting to acetaminophen and small doses of cyclooxygenase-2 inhibitor.
    J Dermatol. 2023 Nov 27. doi: 10.1111/1346-8138.17050.
    PubMed    
    
    
    
17. KANG DH, Kwon SH, Lew BL
    Four-year long-term drug survival of dupilumab analyzed by treatment period in patients with moderate to severe atopic dermatitis: A real-world retrospective study.
    J Dermatol. 2023 Nov 10. doi: 10.1111/1346-8138.17017.
    PubMed    
    
    
    
18. SUEHIRO M, Tanaka A
    A case of atopic dermatitis with self-healing acute diffuse and total alopecia during nemolizumab treatment.
    J Dermatol. 2023 Nov 6. doi: 10.1111/1346-8138.17023.
    PubMed    
    
    
    
19. TAKAMURA S, Nakamura K, Fukuda T
    Evaluation of the safety and effectiveness of berotralstat for patients with hereditary angioedema: Report of six cases.
    J Dermatol. 2023;50:1506-1508.
    PubMed    
    
    
    
20. HIDE M, Ohsawa I, Nurse C, Yu M, et al
    Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open-label study.
    J Dermatol. 2023;50:1381-1391.
    PubMed     Abstract available
    
    
    
21. HIDE M, Wang Y, Dote N, Miyakawa K, et al
    Safety, efficacy, and pharmacokinetics of icatibant treatment in Japanese pediatric patients with hereditary angioedema: A phase 3, open-label study.
    J Dermatol. 2023;50:1473-1477.
    PubMed     Abstract available
    
    
    October 2023
22. ALEGRE-BAILO A, Sanchez-Gilo A, Marlene-Mendoza NM, Mateos-Rico JJ, et al
    Tralokinumab treatment in atopic dermatitis: Depicting super-responders.
    J Dermatol. 2023 Oct 23. doi: 10.1111/1346-8138.17009.
    PubMed    
    
    
    
23. SIMPSON EL, Kircik L, Blauvelt A, Kallender H, et al
    Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxolitinib cream monotherapy.
    J Dermatol. 2023 Oct 13. doi: 10.1111/1346-8138.16975.
    PubMed     Abstract available
    
    
    
24. NAGASHIMA N, Ugajin T, Miyake K, Walls AF, et al
    Cutaneous basophil infiltration in atopic dermatitis is associated with abundant epidermal infiltration of helper T cells: A preliminary retrospective study.
    J Dermatol. 2023 Oct 3. doi: 10.1111/1346-8138.16987.
    PubMed     Abstract available
    
    
    September 2023
25. NAKANE Y, Yoshikawa T, Takeichi T, Kono M, et al
    Dual clinical features of fine and rough scales seen in a combined ichthyosis vulgaris and X-linked recessive ichthyosis patient with atopic dermatitis.
    J Dermatol. 2023 Sep 21. doi: 10.1111/1346-8138.16968.
    PubMed    
    
    
    
26. KATSUTA M, Nobeyama Y, Hirafuku K, Tashiro K, et al
    Characteristics of mild and severe apalutamide-related cutaneous adverse events in patients with prostate cancer: A review of the literature.
    J Dermatol. 2023 Sep 21. doi: 10.1111/1346-8138.16972.
    PubMed     Abstract available
    
    
    
27. HAGINO T, Yoshida M, Hamada R, Fujimoto E, et al
    Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate-to-severe atopic dermatitis.
    J Dermatol. 2023 Sep 4. doi: 10.1111/1346-8138.16950.
    PubMed     Abstract available
    
    
    
28. HIDA T, Ishikawa A, Okura M, Kishibe M, et al
    A Japanese patient with hereditary angioedema caused by deep intron variation in the SERPING1 gene.
    J Dermatol. 2023;50:e309-e310.
    PubMed    
    
    
    
29. TANAKA A, Fujimura Y, Fuke S, Izumi K, et al
    A case of bullous pemphigoid developing under treatment with benralizumab for bronchial asthma.
    J Dermatol. 2023;50:1199-1202.
    PubMed     Abstract available
    
    
    August 2023
30. SAEKI H, Akiyama M, Abe M, Igarashi A, et al
    English version of Japanese guidance for biologics in treating atopic dermatitis.
    J Dermatol. 2023 Aug 31. doi: 10.1111/1346-8138.16932.
    PubMed     Abstract available
    
    
    
31. SEISHIMA M, Sasaki M, Hachiken H, Furukawa T, et al
    Ulcerative colitis during dupilumab therapy in a patient with atopic dermatitis.
    J Dermatol. 2023 Aug 25. doi: 10.1111/1346-8138.16928.
    PubMed    
    
    
    
32. KOBAYASHI Y, Adachi T, Arakawa H, Minakata Y, et al
    A case of drug-induced hypersensitivity syndrome complicated with fulminant type 1 diabetes and type 2 myocardial infarction.
    J Dermatol. 2023 Aug 10. doi: 10.1111/1346-8138.16916.
    PubMed     Abstract available
    
    
    
33. YANG X, Kong M, Wang H, Song Z, et al
    Symptomatic dermographism induced by oral minocycline: A report of four cases.
    J Dermatol. 2023;50:1063-1067.
    PubMed     Abstract available
    
    
    July 2023
34. UCHIDA H, Kamata M, Watanabe A, Ito M, et al
    Improvement of severe alopecia areata after 9-month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis.
    J Dermatol. 2023 Jul 23. doi: 10.1111/1346-8138.16893.
    PubMed    
    
    
    
35. ISHIKAWA Y, Ajima S, Hashizume H
    Pityriasis rubra pilaris with simultaneous emergence of human herpesvirus-6 reactivation in a patient with drug-induced hypersensitivity syndrome.
    J Dermatol. 2023 Jul 19. doi: 10.1111/1346-8138.16877.
    PubMed    
    
    
    
36. MORIMOTO H, Oba M, Shirahama S, Tokura Y, et al
    Docetaxel-induced psoriasis with positive scratch patch test.
    J Dermatol. 2023 Jul 6. doi: 10.1111/1346-8138.16885.
    PubMed    
    
    
    
37. HAGIHARA E, Ito H, Okamoto T, Inomata N, et al
    A case of apple-dependent, exercise-induced anaphylaxis with sensitization to gibberellin-regulated proteins.
    J Dermatol. 2023 Jul 3. doi: 10.1111/1346-8138.16889.
    PubMed    
    
    
    
38. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Background factors predicting the occurrence of herpes zoster in atopic dermatitis patients treated with upadacitinib.
    J Dermatol. 2023 Jul 3. doi: 10.1111/1346-8138.16879.
    PubMed     Abstract available
    
    
    
39. KAWAMURA H, Watanabe T, Yamamura H, Sano S, et al
    Post-orgasmic illness syndrome with positive intradermal test for autologous semen.
    J Dermatol. 2023;50:951-955.
    PubMed     Abstract available
    
    
    June 2023
40. INOUE T, Watabe D, Akasaka K, Sasaki T, et al
    Refractory atopic dermatitis in a child with hypomorphic mutation in XIAP gene and low serum IgG.
    J Dermatol. 2023 Jun 19. doi: 10.1111/1346-8138.16869.
    PubMed    
    
    
    
41. NWIKUE G, Olsson-Brown A, Aboheimed N, Yip V, et al
    TNF-alpha induced extracellular release of keratinocyte high-mobility group box 1 in Stevens-Johnson syndrome/toxic epidermal necrolysis: Biomarker and putative mechanism of pathogenesis.
    J Dermatol. 2023 Jun 2. doi: 10.1111/1346-8138.16847.
    PubMed     Abstract available
    
    
    
42. SUNAGAWA K, Manabe K, Hamada T
    Dermatofibrosarcoma protuberans coexisting with sarcoid reaction in a patient with sarcoidosis.
    J Dermatol. 2023;50:e194-e195.
    PubMed    
    
    
    
43. LEE JW, Yu DA, Cho S, Youn SW, et al
    Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series.
    J Dermatol. 2023;50:814-819.
    PubMed     Abstract available
    
    
    
44. BARIT JJ, Hiroyasu S, Terashima Y, Ayano Y, et al
    Hereditary angioedema with normal C1 inhibitor with steroid responsiveness in a patient with psychiatric comorbidities.
    J Dermatol. 2023;50:e187-e188.
    PubMed    
    
    
    May 2023
45. HIRAI Y, Asada H, Hamada T, Kawada JI, et al
    Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
    J Dermatol. 2023 May 30. doi: 10.1111/1346-8138.16842.
    PubMed     Abstract available
    
    
    
46. KWON IJ, Park JW, Kim SM, Lee KH, et al
    Allergen-specific immunotherapy improves alopecia totalis in a severe atopic dermatitis patient.
    J Dermatol. 2023 May 29. doi: 10.1111/1346-8138.16841.
    PubMed     Abstract available
    
    
    
47. MA L, Zhang L, Kobayashi M, Tao X, et al
    Efficacy and safety of crisaborole ointment in Chinese and Japanese patients aged >/=2 years with mild-to-moderate atopic dermatitis.
    J Dermatol. 2023 May 8. doi: 10.1111/1346-8138.16792.
    PubMed     Abstract available
    
    
    
48. TANAKA N, Nakatani S, Yahiro C, Takai T, et al
    Erythema multiforme associated with cancer radiotherapy: A single-institution case series and literature review.
    J Dermatol. 2023;50:656-663.
    PubMed     Abstract available
    
    
    
49. IRAHARA M, Yamamoto-Hanada K, Sato M, Saito-Abe M, et al
    Endotoxin concentration and persistent eczema in early childhood.
    J Dermatol. 2023;50:646-655.
    PubMed     Abstract available
    
    
    
50. KAWAKAMI T, Yokoyama K, Ikeda T, Nishibata Y, et al
    Similar deposition of neutrophil extracellular traps in the dermis among COVID-19-associated IgA vasculitis, post-COVID-19 vaccination IgA vasculitis, and COVID-19-unrelated IgA vasculitis.
    J Dermatol. 2023;50:e151-e152.
    PubMed    
    
    
    April 2023
51. KANAMOTO M, Takahagi S, Aoyama S, Kido Y, et al
    The expression of prolyl isomerase Pin1 is expanded in the skin of patients with atopic dermatitis and facilitates IL-33 expression in HaCaT cells.
    J Dermatol. 2023;50:462-471.
    PubMed     Abstract available
    
    
    
52. ROH WS, Oh J, Lee MG, Kim TG, et al
    Elevated serum IgE levels are not associated with poor treatment outcome in psoriasis vulgaris.
    J Dermatol. 2023 Apr 1. doi: 10.1111/1346-8138.16795.
    PubMed     Abstract available
    
    
    March 2023
53. TANG Z, Shen M, Man X
    Association between atopic dermatitis and hidradenitis suppurativa: A two-sample Mendelian randomization study.
    J Dermatol. 2023 Mar 29. doi: 10.1111/1346-8138.16796.
    PubMed    
    
    
    
54. NAPOLITANO M, Fabbrocini G, Patruno C
    Dupilumab-associated cutaneous adverse events among adult patients with atopic dermatitis: A retrospective study.
    J Dermatol. 2023 Mar 13. doi: 10.1111/1346-8138.16764.
    PubMed     Abstract available
    
    
    
55. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan.
    J Dermatol. 2023 Mar 8. doi: 10.1111/1346-8138.16763.
    PubMed     Abstract available
    
    
    
56. WANG L, Wang Y, Wang XE, Chen B, et al
    Causal association between atopic eczema and inflammatory bowel disease: A two-sample bidirectional Mendelian randomization study of the East Asian population.
    J Dermatol. 2023;50:327-336.
    PubMed     Abstract available
    
    
    
57. UESUGI-UCHIDA S, Fujisaki M, Sekine S, Takenao C, et al
    Non-episodic angioedema with eosinophilia developing after influenza vaccination: A case report.
    J Dermatol. 2023;50:e96-e97.
    PubMed    
    
    
    February 2023
58. TANAKA R, Kurihara Y, Egami S, Saito Y, et al
    Clinical severity scores as a guide for prediction of initial treatment responses in pemphigus and pemphigoid patients.
    J Dermatol. 2023;50:203-211.
    PubMed     Abstract available
    
    
    January 2023
59. UEDA M, Kogame T, Egawa G, Kambe N, et al
    A case of Kimura disease with atopic dermatitis successfully treated with baricitinib.
    J Dermatol. 2023 Jan 20. doi: 10.1111/1346-8138.16724.
    PubMed    
    
    
    
60. NAKASHIMA C, Kato M, Otsuka A
    Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    J Dermatol. 2023 Jan 13. doi: 10.1111/1346-8138.16651.
    PubMed     Abstract available
    
    
    December 2022
61. HAN J, Stratman S, Young JN, Poplausky D, et al
    Unique protein signatures evolve during the course of a delayed-type hypersensitivity reaction in human skin.
    J Dermatol. 2022 Dec 28. doi: 10.1111/1346-8138.16688.
    PubMed     Abstract available
    
    
    
62. SUZUKI M, Koshikawa S, Watanabe H, Inomata N, et al
    Elevated serum osteopontin levels in patients with severe cutaneous adverse drug reactions.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16670.
    PubMed     Abstract available
    
    
    
63. LI J, Wen W, Mu Z, Du X, et al
    Prevalence of cutaneous manifestations in COVID-19: A meta-analysis.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16672.
    PubMed     Abstract available
    
    
    
64. ZHANG Z, Yu K, Jiang Z, Liu O, et al
    Clinical value of the prognostic nutritional index and red blood cell distribution width-to-albumin ratio for the prediction of severity of and mortality associated with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2022 Dec 7. doi: 10.1111/1346-8138.16661.
    PubMed     Abstract available
    
    
    
65. NAKAGAWA Y, Chinuki Y, Ogino R, Yamasaki K, et al
    Cohort study of subclinical sensitization against galactose-alpha-1,3-galactose in Japan: Prevalence and regional variations.
    J Dermatol. 2022;49:1268-1277.
    PubMed     Abstract available
    
    
    
66. SAITO R, Takahagi S, Nakano F, Furutani K, et al
    A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan.
    J Dermatol. 2022;49:1255-1262.
    PubMed     Abstract available
    
    
    
67. IKEDA T, Yokoyama K, Kawakami T
    Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID-19 vaccine.
    J Dermatol. 2022;49:e446-e447.
    PubMed    
    
    
    November 2022
68. WATANABE T, Watanabe Y, Ikeda N, Aihara M, et al
    Serum levels of C-C motif chemokine ligand 2 and interleukin-8 as possible biomarkers in patients with toxic epidermal necrolysis accompanied by acute respiratory distress syndrome.
    J Dermatol. 2022 Nov 23. doi: 10.1111/1346-8138.16647.
    PubMed     Abstract available
    
    
    
69. SAEKI H, Akiyama M, Abe M, Igarashi A, et al
    English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16635.
    PubMed     Abstract available
    
    
    
70. MIYAKE R, Iwamoto K, Sakai N, Matsunae K, et al
    Uptake of Staphylococcus aureus by keratinocytes is reduced by interferon-fibronectin pathway and filaggrin expression.
    J Dermatol. 2022;49:1148-1157.
    PubMed     Abstract available
    
    
    
71. CHEN H, Zhang G, Zhang P, Long H, et al
    Case of borderline leprosy presenting with urticaria-like eruptions and limbs swelling: A lesson to be learned for dermatologists.
    J Dermatol. 2022;49:e409-e410.
    PubMed    
    
    
    October 2022
72. MIYAJI Y, Yamamoto-Hanada K, Fukuie T, Narita M, et al
    Risk factors of admission in school children with severe atopic dermatitis.
    J Dermatol. 2022 Oct 18. doi: 10.1111/1346-8138.16612.
    PubMed     Abstract available
    
    
    September 2022
73. CHROMY D, Bartosik T, Brkic FF, Quint T, et al
    Dupilumab-induced skin-associated side effects in patients with chronic rhinosinusitis with nasal polyposis.
    J Dermatol. 2022 Sep 30. doi: 10.1111/1346-8138.16595.
    PubMed     Abstract available
    
    
    
74. TOYODA T, Hashimoto K, Ogawa Y, Tohyama M, et al
    Immunohistological analysis of pathogenic infiltrates in the epidermis and liver of a patient with toxic epidermal necrolysis accompanied by vanishing bile duct syndrome.
    J Dermatol. 2022 Sep 29. doi: 10.1111/1346-8138.16576.
    PubMed     Abstract available
    
    
    
75. MIYABE C, Oda T, Miyata R, Miyabe Y, et al
    Nephritis-associated plasmin receptor in the cutaneous vessels in IgA vasculitis.
    J Dermatol. 2022 Sep 24. doi: 10.1111/1346-8138.16574.
    PubMed    
    
    
    
76. LEE ES, Kiuchi Y, Inomata N, Sueki H, et al
    Increased expression of human herpes virus 6 receptor CD134/OX40 in skin lesions of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16575.
    PubMed     Abstract available
    
    
    
77. TANAKA A, Niimi N, Takahashi M, Takahashi H, et al
    Prevalence of skin diseases and prognosis of atopic dermatitis in primary school children in populated areas of Japan from 2010 to 2019: The Asa Study in Hiroshima, Japan.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16577.
    PubMed     Abstract available
    
    
    
78. HATTORI N, Koike Y, Murota H
    Skin microbiome analysis in a case of atopic dermatitis induced by an interleukin 17 inhibitor used to treat psoriasis.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16586.
    PubMed    
    
    
    
79. FENG S, Song G, Liu L, Liu W, et al
    Allergen-specific immunotherapy induces monocyte-derived dendritic cells but attenuates their maturation and cytokine production in the lesional skin of an atopic dermatitis mouse model.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16582.
    PubMed     Abstract available
    
    
    
80. MINAI L, Takeichi T, Ogawa Y, Honobe-Tabuchi A, et al
    Development of pemphigus vegetans and exacerbation of pemphigus foliaceus after secukinumab loading in a patient with complicated generalized pustular psoriasis and pyoderma gangrenosum.
    J Dermatol. 2022 Sep 2. doi: 10.1111/1346-8138.16563.
    PubMed     Abstract available
    
    
    August 2022
81. SAEKI H, Ohya Y, Furuta J, Arakawa H, et al
    English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021.
    J Dermatol. 2022 Aug 22. doi: 10.1111/1346-8138.16527.
    PubMed     Abstract available
    
    
    
82. HAGINO T, Saeki H, Kanda N
    The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan.
    J Dermatol. 2022 Aug 19. doi: 10.1111/1346-8138.16549.
    PubMed     Abstract available
    
    
    
83. YAMASHITA A, Fukui T, Akasaka E, Nakajima K, et al
    A mild case of acute generalized exanthematous pustulosis caused by gemcitabine.
    J Dermatol. 2022;49:e261-e263.
    PubMed    
    
    
    July 2022
84. KAWAKAMI T, Nakade I, Tamura Y, Ito F, et al
    Typical cutaneous small-vessel vasculitis induced by combined injection of antiphosphatidylserine/prothrombin complex antibody and anti-LAMP-2 antibody in normal rats.
    J Dermatol. 2022 Jul 25. doi: 10.1111/1346-8138.16523.
    PubMed     Abstract available
    
    
    
85. KAWAKAMI T, Yokoyama K, Ikeda T, Nishibata Y, et al
    Presence of neutrophil extracellular traps in superficial venous thrombosis of Behcet's disease.
    J Dermatol. 2022;49:741-745.
    PubMed     Abstract available
    
    
    
86. KITAO R, Oda Y, Washio K, Tai Y, et al
    Lower efficacy of omalizumab in older adults with chronic spontaneous urticaria.
    J Dermatol. 2022;49:729-731.
    PubMed     Abstract available
    
    
    June 2022
87. KATOH N, Saeki H, Kataoka Y, Etoh T, et al
    Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16485.
    PubMed     Abstract available
    
    
    
88. CHI MH, Chung WH, Hui RC, Chen CB, et al
    Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16476.
    PubMed     Abstract available
    
    
    
89. CHIANG CP, Hung CT, Chen YH, Chen CY, et al
    Stevens-Johnson syndrome and toxic epidermal necrolysis associated with increased risk of developing psychiatric disorders: A retrospective population-based cohort study in Taiwan.
    J Dermatol. 2022 Jun 10. doi: 10.1111/1346-8138.16487.
    PubMed     Abstract available
    
    
    
90. YANAGIDA N, Takahagi S, Aoyama Y, Tanaka A, et al
    Anhidrosis accompanied by cholinergic urticaria-like rash and dermal pain in a patient with Sjogren's syndrome.
    J Dermatol. 2022;49:666-670.
    PubMed     Abstract available
    
    
    May 2022
91. SALAVA A, Salo V, Remitz A
    Keratosis pilaris and filaggrin loss-of-function mutations in patients with atopic dermatitis - Results of a Finnish cross-sectional study.
    J Dermatol. 2022 May 26. doi: 10.1111/1346-8138.16477.
    PubMed     Abstract available
    
    
    
92. MATSUDATE Y
    Case of allergic contact dermatitis due to nickel contained in stainless steel skull pins.
    J Dermatol. 2022 May 3. doi: 10.1111/1346-8138.16421.
    PubMed    
    
    
    
93. TAKAMIYAGI S, Iriki H, Asahina Y, Furuichi Y, et al
    Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16415.
    PubMed     Abstract available
    
    
    
94. HASHIZUME H, Ajima S, Ishikawa Y
    Immunoglobulin A vasculitis post-severe acute respiratory syndrome coronavirus 2 vaccination and review of reported cases.
    J Dermatol. 2022;49:560-563.
    PubMed     Abstract available
    
    
    April 2022
95. KIMURA H, Umemori Y, Yuki D
    Anaphylactic shock-like symptoms due to niacin overdose: A case report.
    J Dermatol. 2022 Apr 27. doi: 10.1111/1346-8138.16410.
    PubMed    
    
    
    
96. BOMZE D, Sprecher E, Geller S
    Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis.
    J Dermatol. 2022 Apr 27. doi: 10.1111/1346-8138.16398.
    PubMed     Abstract available
    
    
    
97. YU R, Chen S, Pan Y, Ma C, et al
    Combined use of cyclosporine in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2022 Apr 19. doi: 10.1111/1346-8138.16369.
    PubMed     Abstract available
    
    
    
98. KURIHARA K, Fujiyama T, Tokura Y, Honda T, et al
    Possible involvement of interleukin-22-producing CD103(+) CD8(+) T cells in the epidermal hyperplasia of atopic dermatitis.
    J Dermatol. 2022 Apr 1. doi: 10.1111/1346-8138.16382.
    PubMed    
    
    
    
99. GAMBICHLER T, Abu Rached N, Scholl L, Behle B, et al
    Reproducible leukocytoclastic vasculitis following severe acute respiratory syndrome coronavirus 2 vaccination.
    J Dermatol. 2022;49:145-146.
    PubMed    
    
    
    March 2022
100. KAN T, Tanaka A, Kanamoto M, Morioke S, et al
     Longitudinal prevalence of atopic dermatitis among freshmen at Hiroshima University between 2002 and 2019.
     J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16366.
     PubMed     Abstract available
     
     
     
101. MAENO M, Tamagawa-Mineoka R, Arakawa Y, Masuda K, et al
     Facial discoid lupus erythematosus during dupilumab treatment for atopic dermatitis.
     J Dermatol. 2022 Mar 18. doi: 10.1111/1346-8138.16356.
     PubMed    
     
     
     
102. HE W, Hu X, Hua H, Li K, et al
     Allergic contact stomatitis due to desensitizing toothpastes.
     J Dermatol. 2022 Mar 8. doi: 10.1111/1346-8138.16338.
     PubMed     Abstract available
     
     
     
103. MATSUSHIMA Y, Mizutani K, Iida S, Ichishi M, et al
     Severe skin inflammation leads to salivary gland atrophy and dysfunction.
     J Dermatol. 2022 Mar 7. doi: 10.1111/1346-8138.16334.
     PubMed     Abstract available
     
     
     
104. UCHIYAMA A, Fujiwara C, Inoue Y, Motegi SI, et al
     Real-world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single-center retrospective study.
     J Dermatol. 2022 Mar 6. doi: 10.1111/1346-8138.16350.
     PubMed    
     
     
     
105. LEE E, Lee S, Tashiro Y, Ogihara M, et al
     Sequential screening of biomarkers in a case of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms occurring with virus reactivation and autoimmune disease.
     J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16341.
     PubMed    
     
     
     
106. KOREKAWA A, Nakajima K, Fukushi K, Nakano H, et al
     Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines.
     J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16347.
     PubMed     Abstract available
     
     
     
107. KONO T, Miyachi Y, Kawashima M
     Reply to Comment on "Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review".
     J Dermatol. 2022;49:e124.
     PubMed    
     
     
     February 2022
108. OKUNE M, Okiyama N, Fukuzono M, Sasaki K, et al
     Development of systemic lupus erythematosus after dupilumab treatment in a case of atopic dermatitis.
     J Dermatol. 2022 Feb 27. doi: 10.1111/1346-8138.16322.
     PubMed     Abstract available
     
     
     
109. NAKAZAWA S, Phadungsakswasdi P, Kageyama H, Fukuchi K, et al
     Decreased serum level of suprabasin in patients with nickel allergy.
     J Dermatol. 2022 Feb 17. doi: 10.1111/1346-8138.16315.
     PubMed    
     
     
     
110. NISHIOKA K, Koizumi A, Takita Y
     Seven cases of contact dermatitis due to stearyl alcohol contained in topical medications.
     J Dermatol. 2022 Feb 16. doi: 10.1111/1346-8138.16325.
     PubMed     Abstract available
     
     
     
111. HARADA K, Hagiwara T
     Gardner-Diamond syndrome complicated with chronic urticaria successfully treated with antihistamine.
     J Dermatol. 2022;49:e75-e76.
     PubMed    
     
     
     January 2022
112. HATTORI N, Koike Y, Murota H
     Treatment with an interleukin-17 inhibitor resulted in complete remission of psoriasis and flare-up of atopic dermatitis.
     J Dermatol. 2022 Jan 17. doi: 10.1111/1346-8138.16308.
     PubMed    
     
     
     
113. JEDLOWSKI PM, Jedlowski MF
     Coronavirus disease 2019-associated immunoglobulin A vasculitis/Henoch-Schonlein purpura: A case report and review.
     J Dermatol. 2022;49:190-196.
     PubMed     Abstract available
     
     
     
114. JIN WJ, Ahn SW, Jang SH, Hong SM, et al
     Leukocytoclastic vasculitis after coronavirus disease 2019 vaccination.
     J Dermatol. 2022;49:e34-e35.
     PubMed    
     
     
     
115. OHATA M, Oda Y, Washio K, Fukunaga A, et al
     Efficacy of additional treatment for chronic spontaneous urticaria refractory to treatment - A single-center retrospective real-world study.
     J Dermatol. 2022;49:e7-e8.
     PubMed    
     
     
     December 2021
116. BABA A, Kanekura T, Tsubouchi H
     Lichenoid drug eruption after coronavirus disease 2019 vaccination.
     J Dermatol. 2021 Dec 27. doi: 10.1111/1346-8138.16294.
     PubMed    
     
     
     
117. INAZAWA-TERADA M, Namiki T, Omigawa C, Fujimoto T, et al
     An epidemiological survey of anhidrotic/hypohidrotic ectodermal dysplasia in Japan: High prevalence of allergic diseases.
     J Dermatol. 2021 Dec 13. doi: 10.1111/1346-8138.16278.
     PubMed     Abstract available
     
     
     
118. HIRANO Y, Kosumi H, Miyazawa H, Yanagi T, et al
     Toxic epidermal necrolysis induced by tirabrutinib.
     J Dermatol. 2021 Dec 5. doi: 10.1111/1346-8138.16274.
     PubMed    
     
     
     
119. KONO T, Miyachi Y, Kawashima M
     Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review.
     J Dermatol. 2021;48:1807-1816.
     PubMed     Abstract available
     
     
     
120. IWATA H, Kamiya K, Kado S, Nakaya T, et al
     Case of immunoglobulin A vasculitis following coronavirus disease 2019 vaccination.
     J Dermatol. 2021;48:e598-e599.
     PubMed    
     
     
     November 2021
121. MIYAGAWA A, Adachi T, Kobayashi Y, Takamiyagi S, et al
     Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis.
     J Dermatol. 2021 Nov 26. doi: 10.1111/1346-8138.16248.
     PubMed    
     
     
     
122. MATSUMOTO Y, Imamura S, Fukumoto A, Lee K, et al
     Case of oral mite anaphylaxis: Contamination of wheat flour by mites determined by enzyme-linked immunosorbent assay.
     J Dermatol. 2021 Nov 18. doi: 10.1111/1346-8138.16227.
     PubMed    
     
     
     
123. NAKAMURA R, Tanaka A, Kinoshita H, Ishii K, et al
     Minocycline-induced anaphylaxis mediated by antigen-specific immunoglobulin E.
     J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16228.
     PubMed    
     
     
     
124. HASHIZUME H, Ishikawa Y, Ajima S
     Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan.
     J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16230.
     PubMed     Abstract available
     
     
     
125. TOUBI E, Vadasz Z
     Predictive features associated with chronic spontaneous urticaria recurrence.
     J Dermatol. 2021;48:1786-1788.
     PubMed     Abstract available
     
     
     
126. WU RW, Lin TK
     Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis.
     J Dermatol. 2021;48:e562-e563.
     PubMed    
     
     
     
127. MAURELLI M, Bellinato F, Girolomoni G
     Adrenergic urticaria successfully treated with omalizumab.
     J Dermatol. 2021;48:e541-e542.
     PubMed    
     
     
     
128. CHEN TL, Yip HT, Wang JH, Chang CH, et al
     Risk of chronic spontaneous urticaria in reproductive-aged women with abnormal uterine bleeding: A population-based cohort study.
     J Dermatol. 2021;48:1754-1762.
     PubMed     Abstract available
     
     
     
129. OKU A, Nakai K, Ikenaga T, Sato K, et al
     Case of afatinib-induced severe purpuric drug eruption with gastrointestinal bleeding.
     J Dermatol. 2021;48:e534-e535.
     PubMed    
     
     
     October 2021
130. MIURA S, Moriyama T, Yoshimura J, Umehara K, et al
     Anaphylaxis to lipid transfer protein from butterbur scape.
     J Dermatol. 2021 Oct 29. doi: 10.1111/1346-8138.16213.
     PubMed    
     
     
     
131. SATO A, Takemori C, Fukumoto T, Aoyama N, et al
     Cutaneous leukocytoclastic vasculitis induced by thiamazole.
     J Dermatol. 2021 Oct 22. doi: 10.1111/1346-8138.16205.
     PubMed    
     
     
     
132. GOTO T, Kogure A, Kuwano Y
     Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with skin eruptions mimicking acute generalized exanthematous pustulosis.
     J Dermatol. 2021 Oct 8. doi: 10.1111/1346-8138.16190.
     PubMed    
     
     
     
133. KAGE P, Simon JC, Treudler R
     Case of atopic eczema treated with dupilumab throughout conception, pregnancy, and lactation.
     J Dermatol. 2021;48:E484-E485.
     PubMed    
     
     
     
134. KURIYAMA Y, Shimizu A, Oka H, Sato M, et al
     Erythema nodosum-like eruption in coronavirus disease 2019: A case report and literature review of Asian countries.
     J Dermatol. 2021;48:1588-1592.
     PubMed     Abstract available
     
     
     
135. LIU KL, Tsai TL, Tsai WC, Tsai SF, et al
     Prenatal heavy metal exposure, total immunoglobulin E, trajectory, and atopic diseases: A 15-year follow-up study of a Taiwanese birth cohort.
     J Dermatol. 2021;48:1542-1549.
     PubMed     Abstract available
     
     
     September 2021
136. HUANG HL, Xu HM, Liu YD, Shou DW, et al
     Fecal microbiota transplantation as a novel approach for the treatment of atopic dermatitis.
     J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16169.
     PubMed    
     
     
     
137. KIDO-NAKAHARA M, Yokote G, Yoshida M, Furue M, et al
     Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.
     J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16176.
     PubMed    
     
     
     
138. ADACHI M, Adachi T, Yokota M, Ichimura C, et al
     A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
     J Dermatol. 2021 Sep 24. doi: 10.1111/1346-8138.16173.
     PubMed    
     
     
     August 2021
139. KAWANO N, Inoue H, Shiratori T
     Onset of Stevens-Johnson syndrome and toxic epidermal necrolysis overlap due to tirabrutinib.
     J Dermatol. 2021 Aug 4. doi: 10.1111/1346-8138.16093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.